CLINICAL_TRIALS
trial_result
· 2021-03-18
Clinical Trial Update: Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation [Phase 3]
Summary
A Phase 3 trial evaluating clinical equivalence between two linaclotide products for chronic idiopathic constipation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Chronic Idiopathic Constipation | Phase 3 | Status: UNKNOWN